Repercussões tardias de um programa de reabilitação pulmonar sobre os índices de ansiedade, depressão, qualidade de vida e desempenho físico em portadores de DPOC

Godoy, Rossane Frizzo de; Teixeira, Paulo José Zimermann; Júnior, Benno Becker; Michelli, Maurício; Godoy, Dagoberto Vanoni de

doi:10.1590/s1806-37132009000200005

Cited by 29 publications

(12 citation statements)

References 26 publications

(23 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This strategy, which provides access to rehabilitation opportunities for all, was based on a study in which the authors concluded that the benefits of a rehabilitation program on the indices of anxiety, depression, quality of life, and exercise capacity persisted over 24 months in patients with COPD. ( 30 ) …”

Section: Discussionmentioning

confidence: 99%

Impact of pulmonary rehabilitation on quality of life and functional capacity in patients on waiting lists for lung transplantation

et al. 2013

View full text Add to dashboard Cite

OBJECTIVE: To investigate the impact of a pulmonary rehabilitation program on the functional capacity and on the quality of life of patients on waiting lists for lung transplantation. METHODS: Patients on lung transplant waiting lists were referred to a pulmonary rehabilitation program consisting of 36 sessions. Before and after the program, participating patients were evaluated with the six-minute walk test and the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36). The pulmonary rehabilitation program involved muscle strengthening exercises, aerobic training, clinical evaluation, psychiatric evaluation, nutritional counseling, social assistance, and educational lectures. RESULTS: Of the 112 patients initially referred to the program, 58 completed it. The mean age of the participants was 46 ± 14 years, and females accounted for 52%. Of those 58 patients, 37 (47%) had pulmonary fibrosis, 13 (22%) had pulmonary emphysema, and 18 (31%) had other types of advanced lung disease. The six-minute walk distance was significantly greater after the program than before (439 ± 114 m vs. 367 ± 136 m, p = 0.001), the mean increase being 72 m. There were significant point increases in the scores on the following SF-36 domains: physical functioning, up 22 (p = 0.001), role-physical, up 10 (p = 0.045); vitality, up 10 (p < 0.001); social functioning, up 15 (p = 0.001); and mental health, up 8 (p = 0.001). CONCLUSIONS: Pulmonary rehabilitation had a positive impact on exercise capacity and quality of life in patients on lung transplant waiting lists.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of pulmonary rehabilitation on quality of life and functional capacity in patients on waiting lists for lung transplantation

et al. 2013

View full text Add to dashboard Cite

show abstract

“…A few other studies have found reduction in anxiety and depression after pulmonary rehabilitation in patients with COPD. [26–28]…”

Section: Evidence For Effectiveness Of Pulmonary Rehabilitationmentioning

confidence: 99%

Pulmonary rehabilitation: An overview

Sharma

Singh

2011

Lung India

View full text Add to dashboard Cite

The burden of chronic obstructive pulmonary disease (COPD) has increased recently in developing countries. On the other hand, structured or non-structured rehabilitation services for COPD patients are not routinely available in these countries. We, therefore, planned this review to re-emphasize the emerging benefits of pulmonary rehabilitation in COPD population. Aim of this review is to stimulate pulmonary physicians in India and other resource-poor areas of the world so that they start using pulmonary rehabilitation or its components more often. The search included standard english literature PubMed citation of relevant original articles, review articles and practice guidelines. The articles and reviews were searched including standard MeSH terms – Rehabilitation (TIAB) and pulmonary disease, chronic obstructive/therapy (MAJOR) and guidelines (TIAB). Available 58 articles in English including 23 reviews from July 2001 to October 2010 were screened for evidence-based benefits regarding respiratory rehabilitation as a whole or its different components. The cross references and current citations relating to primary articles were also included for description. No attempt was done to make a systematic analysis because our purpose was not to derive evidence-based recommendations from database and because sufficient evidence is already available for benefits of selected components of pulmonary rehabilitation in COPD patients. Pulmonary rehabilitation has emerged as an important modality as an adjunct to other therapies in patients of COPD. Limited and more cost-effective protocols are to be developed and executed by healthcare providers, especially in developing countries like India.

show abstract

“…Godoy et al4 reported that the benefits provided by a pulmonary rehabilitation program, in terms of the indices of QOL as well as improved 6-minute walk test performance, persisted throughout the 24-month study period, in patients with COPD. Pulmonary rehabilitation does not always need to be conventional.…”

Section: Introductionmentioning

confidence: 99%

Effect of repeated Waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial

Kikuchi¹,

Shiozawa²,

Takata³

et al. 2013

COPD

View full text Add to dashboard Cite

PurposeControlled clinical trials evaluating the efficacy of repeated Waon therapy for patients with chronic obstructive pulmonary disease (COPD) have yet to be conducted. The purpose of the present study was to evaluate whether repeated Waon therapy exhibits an adjuvant effect on conventional therapy for COPD patients.Patients and methodsThis prospective trial comprised 20 consecutive COPD patients who satisfied the criteria of the Global initiative for chronic Obstructive Lung Disease (GOLD) guidelines, stages 1–4. They were assigned to either a Waon or control group. The patients in the Waon group received both repeated Waon therapy and conventional therapy, including medications, such as long-acting inhaled β2 agonists, long-acting anticholinergics and xanthine derivatives, and pulmonary rehabilitation. The Waon therapy consisted of sitting in a 60°C sauna room for 15 minutes, followed by 30 minutes of being warmed with blankets once a day, 5 days a week, for a total of 20 times. The patients in the control group received only conventional therapy. Pulmonary function and the 6-minute walk test were assessed before and at 4 weeks after the program.ResultsThe change in vital capacity (0.30 ± 0.4 L) and in peak expiratory flow (0.48 ± 0.79 L/s) in the Waon group was larger than the change in the vital capacity (0.02 ± 0.21 L) (P=0.077) and peak expiratory flow (−0.11 ± 0.72 L/s) (P=0.095) in the control group. The change in forced expiratory flow after 50% of expired forced vital capacity in the Waon group, 0.08 (0.01–0.212 L/s), was larger than that in the control group, −0.01 (−0.075–0.04 L/s) (P=0.019). Significant differences were not observed in the change in any parameters in the 6-minute walk test. Data are presented as means ± standard deviation or median (25th–75th percentile).ConclusionThe addition of repeated Waon therapy to conventional therapy for COPD patients can possibly improve airway obstruction.

show abstract

Repercussões tardias de um programa de reabilitação pulmonar sobre os índices de ansiedade, depressão, qualidade de vida e desempenho físico em portadores de DPOC

Cited by 29 publications

References 26 publications

Impact of pulmonary rehabilitation on quality of life and functional capacity in patients on waiting lists for lung transplantation

Impact of pulmonary rehabilitation on quality of life and functional capacity in patients on waiting lists for lung transplantation

Pulmonary rehabilitation: An overview

Effect of repeated Waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial

Contact Info

Product

Resources

About